XML 191 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 236 $ 328
Short-term investments 3 4
Accounts receivable, net 1,411 1,130
Inventories 1,597 1,172
Prepaid expenses 62 63
Total current assets 3,309 2,697
Property, plant and equipment, net of accumulated depreciation of $3,326 and $3,232, respectively 2,407 2,423
Intangible assets 1,301 1,348
Other assets 544 531
Total assets 7,561 6,999
Current liabilities:    
Short-term borrowings 543 308
Accounts payable 873 774
Accrued liabilities 466 430
Total current liabilities 1,882 1,512
Long-term debt 1,940 1,738
Other non-current liabilities 477 524
Total liabilities 4,299 3,774
Share-based payments subject to redemption 48 36
Redeemable non-controlling interests 51 71
Ingredion stockholders’ equity:    
Preferred stock — authorized 25,000,000 shares — $0.01 par value, none issued 0 0
Common stock — authorized 200,000,000 shares — $0.01 par value, 77,810,875 issued at December 31, 2022 and December 31, 2021 1 1
Additional paid-in capital 1,132 1,158
Less: Treasury stock (common stock: 12,116,920 and 11,154,203 shares at December 31, 2022 and December 31, 2021, respectively) at cost (1,148) (1,061)
Accumulated other comprehensive loss (1,048) (897)
Retained earnings 4,210 3,899
Total Ingredion stockholders’ equity 3,147 3,100
Non-redeemable non-controlling interests 16 18
Total equity 3,163 3,118
Total liabilities and equity $ 7,561 $ 6,999